Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations - Concepedia

Concepedia

Publication | Open Access

Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations

DOI Full Paper Access

52

Citations

12

References

2022

Year

Mariona Riudavets, Édouard Auclin, Miguel Mosteiro, Naomi Dempsey, Margarita Majem, Riccardo Lobefaro, Rafael López Castro, Joaquim Bosch‐Barrera, Sara Pilotto, E. Escalera,

European Journal of Cancer

MedicinePathologyCancer GenomicsBronchial NeoplasmDurvalumab ConsolidationDriver Genomic AlterationsOncologyRadiation OncologyLung Cancer

References

	Year	Citations

Page 1

Page 1